Zühlke Ventures
Switzerlandzuehlke.com
Overview
Zühlke Ventures is the corporate venture capital arm of Zühlke Group, a global technology and business innovation service provider. Founded in 2011, the firm specializes in early-stage investments in high-tech startups, with a current exclusive focus on the HealthTech sector. It provides portfolio companies with financing, management and technology expertise, and access to the broader Zühlke Group network. Zühlke Ventures primarily invests in Switzerland and Europe, holding minority stakes with initial investments typically ranging from CHF 150,000 to CHF 250,000.
Portfolio Companies
10
Website
zuehlke.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PeriVision | Sep 2025 | Seed | Co-investor |
| Limula | May 2024 | Seed | Co-investor |
| Indivi | Aug 2022 | Early Funding | Co-investor |
| evismo | Sep 2021 | Seed | Lead |
| Flow Neuroscience | Aug 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.